A new AI system for screening and treating cervical cancer in low and middle-income countries.
Official title: A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs
Funded at International Agency for Res on Cancer · NIH-10904621 · Data updated 2026-11-12
This study is working on a new AI system that helps check women for cervical cancer and related issues by looking at urine samples and images of the cervix, especially aimed at helping women in low and middle-income countries where cervical cancer is more common.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | International Agency for Res on Cancer NIH-funded |
| Lab location | 1 site (Lyon, France) |
| Project start | August 15, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $491,802 |
| NIH project number | 5R37CA275824-02 |
| Project ID | NIH-10904621 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women in low and middle-income countries who have not been screened for cervical cancer.
✕Less likely to help
Patients who have already been diagnosed with cervical cancer or those who have received prior treatment may not benefit from this research.
What this research studies
This research aims to develop an innovative artificial intelligence (AI) system that screens and triages women for cervical cancer and precancerous conditions using urine samples and cervical images. The AI will analyze infrared spectroscopic signals from urine to detect high-risk Human Papillomavirus (hr-HPV) and interpret images of the cervix to identify high-grade precancers and cancers. The project will be conducted in two phases: the first phase focuses on improving the technology and the second phase on validating its effectiveness. This approach is particularly targeted at women in low and middle-income countries where cervical cancer is prevalent.
Why it matters
Potential benefit: If successful, this research could provide a cost-effective and efficient method for early detection and treatment of cervical cancer, potentially saving lives.
How similar studies have gone: Other research has shown promising results using AI for cancer detection, indicating that this approach has potential for success.
Where this research is happening
-
International Agency for Res on Cancer
Lyon, France Active
Researchers
- Principal investigator: Basu, Partha — International Agency for Res on Cancer
- Study coordinator: Basu, Partha
Related research
Other NIH-funded projects on the same topics.
-
Community and digital tools to reduce HPV and cervical cancer burden
A nurse or health team will test a community-based, digital strategy to help girls and young women, especially in rural areas, get HPV vaccination and cervical cancer prevention services.
-
Community and digital tools to reduce HPV and cervical cancer in women with HIV
A community- and digital-technology program aims to help girls and young women, including those with HIV, get more HPV vaccination and cervical cancer prevention services.
-
mSaada: a mobile tool to boost cervical cancer screening in western Kenya
A mobile app helps community health volunteers manage cervical cancer screening tasks and follow-up for women in low-resource areas.
-
Globally useful predictor for cervical cancer treatment response
This project aims to develop a simple predictive signature to personalize treatment for locally advanced cervical cancer using easy tests and imaging.
-
HPV self-collection in HIV care to screen for cervical cancer in Ethiopia
A patient-centered program tests a simple HPV self-collection approach within HIV clinics in Ethiopia to help detect cervical cancer earlier.
-
Hybrid approach to boost cervical cancer screening in Uganda
A tested, community-driven program helps Ugandan women encourage their peers to get free VIA cervical cancer screening.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.